Previous close | 117.60 |
Open | 117.78 |
Bid | 124.36 x 100 |
Ask | 124.74 x 200 |
Day's range | 116.00 - 124.51 |
52-week range | 36.42 - 124.51 |
Volume | |
Avg. volume | 858,293 |
Market cap | 4.088B |
Beta (5Y monthly) | 1.98 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.34 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 119.20 |
According to the average brokerage recommendation (ABR), one should invest in TransMedics (TMDX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Q1 2024 Transmedics Group Inc Earnings Call
Explore how TransMedics Group Inc achieved a 133% year-over-year revenue growth and strategic expansions in Q1 2024.